Javascript must be enabled to continue!
crispr/cas9-targeted Mutagenesis of KTI1 and KTI3 to Reduce Trypsin Inhibitors in Soybean Seeds
View through CrossRef
Trypsin inhibitor (TI) in soybean seeds, restrains the function of trypsin, causing low protein digestibility when raw soybeans are fed to animals. Heat treatment has been widely used to deactivate TI, but it is energy-intensive and costly, and degrades protein quality. Despite a few soybean accessions harboring natural low TI content have been identified, multiple TI genes and lacking of gene-based markers still hinder the breeding success of low TI soybean cultivars. The objectives of this study were to concisely edit the major genes contributing to the TI content and activity specifically in the soybean seeds using CRISPR/Cas9 system, and develop allele-specific molecular markers based on the generated mutant alleles. With the aid of TI gene expression data and real-time PCR results, KTI1 (Glyma01g095000) and KTI3 (Glyma08g341500), were selected as the target genes. Then, we developed a productive CRISPR/Cas9 construct for the transformation on Glycine max cv. Williams 82. (WM82). The results showed that in the seeds at T0 generation, the gene editing has been all complete for KTI1 while it has been partly finished for KTI3. Consistent with genotyping results, the TI content and activity in gene edited seeds declined 70% and 10% with knock-out of KTI1 alone and 90% and 30% with knock-out of both KTI1 and KTI3, which were also both lower than that in the seeds of PI 547656, the natural low TI soybean accession. Furthermore, in T1 seeds, we collected one transgene free line #5-26 with double homozygous mutations. Based on the mutant alleles in #5-26, we developed molecular markers to effectively screen the mutant alleles of KTI1 and KTI3 for the perspective breeding of low TI soybean varieties. The soybean line and selection markers acquired from this study will assist in accelerating the introduction of low TI trait to elite soybean cultivars with added-value.
American Oil Chemists' Society (AOCS)
Title: crispr/cas9-targeted Mutagenesis of KTI1 and KTI3 to Reduce Trypsin Inhibitors in Soybean Seeds
Description:
Trypsin inhibitor (TI) in soybean seeds, restrains the function of trypsin, causing low protein digestibility when raw soybeans are fed to animals.
Heat treatment has been widely used to deactivate TI, but it is energy-intensive and costly, and degrades protein quality.
Despite a few soybean accessions harboring natural low TI content have been identified, multiple TI genes and lacking of gene-based markers still hinder the breeding success of low TI soybean cultivars.
The objectives of this study were to concisely edit the major genes contributing to the TI content and activity specifically in the soybean seeds using CRISPR/Cas9 system, and develop allele-specific molecular markers based on the generated mutant alleles.
With the aid of TI gene expression data and real-time PCR results, KTI1 (Glyma01g095000) and KTI3 (Glyma08g341500), were selected as the target genes.
Then, we developed a productive CRISPR/Cas9 construct for the transformation on Glycine max cv.
Williams 82.
(WM82).
The results showed that in the seeds at T0 generation, the gene editing has been all complete for KTI1 while it has been partly finished for KTI3.
Consistent with genotyping results, the TI content and activity in gene edited seeds declined 70% and 10% with knock-out of KTI1 alone and 90% and 30% with knock-out of both KTI1 and KTI3, which were also both lower than that in the seeds of PI 547656, the natural low TI soybean accession.
Furthermore, in T1 seeds, we collected one transgene free line #5-26 with double homozygous mutations.
Based on the mutant alleles in #5-26, we developed molecular markers to effectively screen the mutant alleles of KTI1 and KTI3 for the perspective breeding of low TI soybean varieties.
The soybean line and selection markers acquired from this study will assist in accelerating the introduction of low TI trait to elite soybean cultivars with added-value.
Related Results
Introduction to CRISPR/Cas9
Introduction to CRISPR/Cas9
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Genome engineering using CRISPR
Genome engineering using CRISPR
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Row Orientation and Planting Pattern of Relay Intercropped Soybean and Wheat
Row Orientation and Planting Pattern of Relay Intercropped Soybean and Wheat
Relay intercropping soybean [Glycine max(L.) Merr.] into winter wheat (Triticum aestivum L.) may increase soybean yields compared with doublecropping. Once the soybean crop is esta...
PERKEMBANGAN TEKNOLOGI CRISPR-CAS9 DALAM TERAPI PENYAKIT ANEMIA SEL SABIT PADA MANUSIA - A REVIU
PERKEMBANGAN TEKNOLOGI CRISPR-CAS9 DALAM TERAPI PENYAKIT ANEMIA SEL SABIT PADA MANUSIA - A REVIU
Belum adanya terapi yang menjanjikan atas penyembuhan penyakit genetik anemia sel sabit (Sickle Cell Disease/SCD) yang disebabkan oleh mutasi gen, dan bila dimungkinkan terdapat te...
Clustered Regularly Interspaced Short Palindromic Repeat Paired Associated Protein 9 (CRISPR-Cas9) System and Its Opportunity in Medical Science - A Narrative Review
Clustered Regularly Interspaced Short Palindromic Repeat Paired Associated Protein 9 (CRISPR-Cas9) System and Its Opportunity in Medical Science - A Narrative Review
The clustered regularly interspaced short palindromic repeat paired associated protein 9 (CRISPR-Cas9) is a site-specific genome editing tool that enables scientists to edit or int...
ets for CRISPR/Cas9-mediated gene drive in Bemisia tabaci
ets for CRISPR/Cas9-mediated gene drive in Bemisia tabaci
The goal of our BARD proposal was to build both the necessary infrastructure and knowledge for using the CRISPR/Cas9-based gene drive system to control the whitefly Bemisia tabaci....
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
THE FUTURE OF MEDICINE: ADVANCING GENE THERAPY WITH CRISPR-CAS9’S EXACT PRECISION IN PEDIATRIC MALES
The revolutionary potential of CRISPR-Cas9 in medicine lies in its unparalleled precision in gene editing, heralding a new era for treating genetic disorders. This study focuses on...
Tinjauan Literatur Sistematis; Pemanfaatan Teknologi CRISPR-CAS9 Untuk Pengobatan Penyakit Huntington’s
Tinjauan Literatur Sistematis; Pemanfaatan Teknologi CRISPR-CAS9 Untuk Pengobatan Penyakit Huntington’s
A Systematic Literature Review: Utilization of CRISPR-CAS9 Technology for Treating Huntington's Disease
Huntington's Disease (HD) is a neurodegenerative disorder caused by a CAG tr...

